Sederma introduces Sebuless, a new multifunctional ingredient designed and demonstrated to mattify and equalise the skin tone of oily and acne-prone skin, in just one month.
With the use of an unprecedented in vitro test method on normal human sebocytes as a more reliable and predictive model associated with cosmetogenomics, Sederma was able to confirm a positive action on every known process leading to oily skin and associated blemishes: hyperseborrhea, microbial proliferation, inflammation, hyperkeratinisation and hyperpigmentation. This pool of innovative in vitro tests not only allowed for the validation of efficacy of Sebuless, but also provided an increased understanding of its mechanism of action at each of the various steps. To further validate its efficacy in vivo, a consumer study was carried out on 100 volunteers (mean age 24) and demonstrated that Sebuless, within only one month, made the skin less shiny for 70% of the panel. There was a consumer-perceivable improvement in the appearance of pimples and red spots with over 70% of volunteers reporting a more purified skin appearance. This high-tech active ingredient is derived from plant cell culture and thus offers a natural and gentle cosmetic solution to treat oily and acneprone skin, globally.
